JIFs have been a prominent means of ranking journals for decades. However, the scientific community is starting to replace this methodology in order to better quantify and capture a journal’s true impact.
We look at four of the key challenges facing pharma companies as they look to leverage huge amounts of scientific research
A major step forward in cancer research was made this fall when the National Institute of Health (NIH) and 11 of the top biopharmaceutical companies formed the Partnership for Accelerated Cancer Treatment (PACT)
Back in October, the Food and Drug Administration (FDA) published a series of documents regarding Abbreviated New Drug Applications (ANDAs) for the “genericization” of drugs, with an emphasis placed on simplifying the process by which companies can produce generic versions of complex drugs. Here is your guide.